Literature DB >> 17024861

A comparative study of regression of jaundice in patients of malaria and acute viral hepatitis.

D K Kochar1, K Kaswan, S K Kochar, P Sirohi, M Pal, A Kochar, R P Agrawal, A Das.   

Abstract

BACKGROUND &
OBJECTIVES: Jaundice is one of the common manifestations of severe malaria in adults. The purpose of this study is to compare the pattern of clinical and biochemical parameters such as serum bilirubin and liver enzyme levels in patients of malaria with jaundice and acute viral hepatitis.
METHODOLOGY: The present study was conducted on 34 patients of malaria with jaundice and 15 patients of acute viral hepatitis. Estimation of serum bilirubin, aspartate amino transferase (AST), alanine amino transferase (ALT) and alkaline phosphatase was done daily using standard procedures in malaria patients and weekly in acute viral hepatitis patients.
RESULTS: Mean level of serum bilirubin on first day in malaria and acute viral hepatitis patients was 7.07 +/- 3.94 and 10.38 +/- 7.87 mg%, whereas on Day 8 it was 1.19 +/- 1.43 and 7.88 +/- 7.02 mg% respectively. Mean level of AST on Day 1 in malaria and acute viral hepatitis patients was 158.47 +/- 120.35 and 1418.6 +/- 834.11 IU/L, whereas on Day 8 it was 41 +/- 28.33 and 775.3 +/- 399.01 IU/L respectively. Mean level of ALT on Day 1 in malaria and acute viral hepatitis patients was 220.14 +/- 145.61 and 1666.67 +/- 1112.77 IU/L, whereas on Day 8 it was 50.85 +/- 37.31 and 823.8 +/- 475.06 IU/L respectively. Mean level of serum alkaline phosphatase on Day 1 in malaria and acute viral hepatitis patients was 394.74 +/- 267.78 and 513.4 +/- 324.7 IU/L, whereas on Day 8 it was 84.76 +/- 68.50 and 369.27 +/- 207.75 IU/L respectively. INTERPRETATION &
CONCLUSION: We observed that resolution of jaundice in malaria took 1-2 weeks in contrast 6 to 8 weeks in viral hepatitis. This difference in duration was statistically significant. Thus, jaundice not resolving in 1-2 weeks time in a patient of malaria requires serious consideration for presence of other concomitant diseases including viral hepatitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17024861

Source DB:  PubMed          Journal:  J Vector Borne Dis        ISSN: 0972-9062            Impact factor:   1.688


  9 in total

1.  Clinical profile of severe malaria: study from a tertiary care center in north India.

Authors:  Shafali Nandwani; Apurva Pande; Mahip Saluja
Journal:  J Parasit Dis       Date:  2012-11-21

2.  Association of heme oxygenase 1 with the restoration of liver function after damage in murine malaria by Plasmodium yoelii.

Authors:  Sumanta Dey; Somnath Mazumder; Asim Azhar Siddiqui; M Shameel Iqbal; Chinmoy Banerjee; Souvik Sarkar; Rudranil De; Manish Goyal; Samik Bindu; Uday Bandyopadhyay
Journal:  Infect Immun       Date:  2014-05-12       Impact factor: 3.441

3.  Resolution pattern of jaundice among children presenting with severe malaria in rural South-West Nigeria.

Authors:  O A Osonuga; A Osonuga; A A Osonuga; I O Osonuga
Journal:  Asian Pac J Trop Biomed       Date:  2012-07

4.  Prevalence and clinical manifestations of malaria in Aligarh, India.

Authors:  Umm-e Asma; Farha Taufiq; Wajihullah Khan
Journal:  Korean J Parasitol       Date:  2014-12-23       Impact factor: 1.341

5.  The Dynamics of Liver Function Test Abnormalities after Malaria Infection: A Retrospective Observational Study.

Authors:  John Woodford; G Dennis Shanks; Paul Griffin; Stephan Chalon; James S McCarthy
Journal:  Am J Trop Med Hyg       Date:  2018-02-08       Impact factor: 2.345

6.  Discriminating Clinical and Biological Features in Malaria and Dengue Patients.

Authors:  Wajihullah Khan; Haytham A Zakai; Khadija Khan; Sharba Kausar; Sana Aqeel
Journal:  J Arthropod Borne Dis       Date:  2018-06-13       Impact factor: 1.198

7.  The Impact of Malaria on Liver Enzymes: A Retrospective Cohort Study (2010-2017).

Authors:  James Cheaveau; Dewdunee Marasinghe; Samantha Akakpo; Rob Deardon; Christopher Naugler; Alex Chin; Dylan R Pillai
Journal:  Open Forum Infect Dis       Date:  2019-05-16       Impact factor: 3.835

8.  Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission.

Authors:  Paul Griffin; Cielo Pasay; Suzanne Elliott; Silvana Sekuloski; Maggy Sikulu; Leon Hugo; David Khoury; Deborah Cromer; Miles Davenport; Jetsumon Sattabongkot; Karen Ivinson; Christian Ockenhouse; James McCarthy
Journal:  PLoS Negl Trop Dis       Date:  2016-12-08

9.  Liver Function Test Abnormalities in Experimental and Clinical Plasmodium vivax Infection.

Authors:  Anand Odedra; Lachlan Webb; Louise Marquart; Laurence J Britton; Stephan Chalon; Joerg J Moehrle; Nicholas M Anstey; Timothy William; Matthew J Grigg; David G Lalloo; Bridget E Barber; James S McCarthy
Journal:  Am J Trop Med Hyg       Date:  2020-11       Impact factor: 2.345

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.